كشفت دراسة نشرتها مجلة The Lancet أن النساء المصابات بمتلازمة تكيس المبايض يواجهن خطرًا أعلى بأربع مرات للإصابة بأمراض القلب، حتى بعد استبعاد عوامل الخطر التقليدية. الدراسة حللت بيانات أكثر من 400 ألف امرأة ودعت لتحسين التشخيص ورفع الوعي بالمخاطر.
New NHS guidance recommends annual checks for women with Polyendocrine Metabolic Ovarian Syndrome (PMOS), formerly Polycystic Ovary Syndrome. The condition affects 1 in 8 women and is linked to infertility, irregular periods, and risks like diabetes and heart disease. NICE urges faster diagnosis and better monitoring.
New NHS guidance suggests investigating up to 4 million women with irregular periods for Polyendocrine Metabolic Ovarian Syndrome (PMOS), previously known as Polycystic Ovarian Syndrome. The condition, affecting up to 13% of reproductive-age women, is often underdiagnosed and inconsistently managed. The guidance covers a wider demographic and emphasizes annual reviews for monitoring symptoms and associated health risks.
Briony May Williams, a former teacher, turned to baking to cope with PMOS symptoms in 2013. This led to her appearance on Bake Off and a career as a TV presenter. She now advocates for increased public awareness and faster diagnosis of PMOS, formerly known as PCOS.
Yıllardır Polikistik Over Sendromu (PKOS) olarak bilinen hastalık, artık Poliendokrin Metabolik Over Sendromu (PMOS) olarak adlandırılacak. Bu isim değişikliği, hastalığın sadece yumurtalıklarla sınırlı olmadığını, temelinde hormonal ve metabolik bozukluklar yattığını vurguluyor. Yeni isim, doğru teşhis ve tedaviye yol açmayı hedefliyor.
Transgender teenagers are struggling to access gender-affirming care as clinics close nationwide due to political pressure and funding threats. Stories highlight the emotional and medical toll on young people like Sage, who faced abrupt care cessation, and the broader societal challenges in hearing and validating their experiences.
The renaming of PCOS to PMOS highlights the complexity of the condition, affecting 170 million women worldwide with varied symptoms. While health tech companies promise personalized health solutions, the author's experience with PMOS and its diverse manifestations among sufferers underscores the challenges in providing effective, individualized health tech for complex conditions.
Polycystic Ovary Syndrome (PCOS), affecting over 3 million UK women, is renamed Polyendocrine Metabolic Ovarian Syndrome (PMOS) to reflect its complex hormonal nature, aiming to improve diagnoses and treatment.
Polycystic ovary syndrome (PCOS) has been renamed to polyendocrine metabolic ovarian syndrome (PMOS) to better reflect its systemic impact beyond ovarian cysts, affecting nearly one in eight women globally
